메뉴 건너뛰기




Volumn 41, Issue 4, 2009, Pages 941-945

Renal AA amyloidosis: Survey of epidemiologic and laboratory data from one nephrology centre

Author keywords

AA amyloidosis; Chronic kidney disease; Epidemiology; Nephrotic syndrome; Renal involvement

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; PREDNISONE;

EID: 77954564338     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9524-2     Document Type: Article
Times cited : (16)

References (21)
  • 2
    • 0025936525 scopus 로고
    • Secondary systemic amyloidosis: Response and survival in 64 patients
    • doi:10. 1097/00005792-199107000-00002
    • Gertz MA, Kyle RA (1991) Secondary systemic amyloidosis: response and survival in 64 patients. Medicine 70:246-256. doi:10. 1097/00005792-199107000- 00002
    • (1991) Medicine , vol.70 , pp. 246-256
    • Ma, G.1    Kyle, R.A.2
  • 3
    • 0028087628 scopus 로고
    • Clinical and therapeutic aspects of aa amyloidosis
    • doi:10. 1016/S0950-3579(05) 80121-9
    • Hazenberg BP, van Rijswijk MH (1994) Clinical and therapeutic aspects of AA amyloidosis. Baillieres Clin Rheumatol 8:661-690. doi:10. 1016/S0950-3579(05) 80121-9
    • (1994) Baillieres Clin Rheumatol , vol.8 , pp. 661-690
    • Hazenberg, B.P.1    Van Rijswijk, M.H.2
  • 4
    • 1842866229 scopus 로고    scopus 로고
    • Clinical and genetic aspects of the hereditary periodic fever syndromes
    • doi:10. 1093/rheumatology/keh157
    • Grateau G (2004) Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology 43:410-415. doi:10. 1093/rheumatology/keh157
    • (2004) Rheumatology , vol.43 , pp. 410-415
    • Grateau, G.1
  • 6
    • 0036176146 scopus 로고    scopus 로고
    • Pathology, diagnosis and pathogenesis of aa amyloidosis
    • doi:10. 1007/s00428-001-0582-9
    • Rocken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111-122. doi:10. 1007/s00428-001-0582-9
    • (2002) Virchows Arch , vol.440 , pp. 111-122
    • Rocken, C.1    Shakespeare, A.2
  • 7
    • 0032918632 scopus 로고    scopus 로고
    • Serum amyloid a (saa). A concise review of biology, assay methods and clinical usefulness
    • doi:10. 1515/CCLM. 1999.063
    • Yamada T (1999) Serum amyloid A (SAA). A concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 37:381-388. doi:10. 1515/CCLM. 1999.063
    • (1999) Clin Chem Lab Med , vol.37 , pp. 381-388
    • Yamada, T.1
  • 8
    • 0033548474 scopus 로고    scopus 로고
    • The heparin/heparan sulfate-binding site on apo-serum amyloid a: Implications for the therapeutic intervention of amyloidosis
    • doi:10. 1074/jbc.274.11. 7172
    • Ancsin JB, Kisilevsky R (1999) The heparin/heparan sulfate-binding site on apo-serum amyloid A: implications for the therapeutic intervention of amyloidosis. J Biol Chem 274:7172-7181. doi:10. 1074/jbc.274.11. 7172
    • (1999) J Biol Chem , vol.274 , pp. 7172-7181
    • Ancsin, J.B.1    Kisilevsky, R.2
  • 9
    • 9444263075 scopus 로고    scopus 로고
    • Amyloidogenesis recapitulated in cell culture. A peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy
    • Elimova E, Kisilevsky R, Szarek WA, Ancsin JB (2004) Amyloidogenesis recapitulated in cell culture. A peptide inhibitor provides direct evidence for the role of heparan sulfate and suggests a new treatment strategy. FASEB J 18:1749-1751
    • (2004) FASEB J , vol.18 , pp. 1749-1751
    • Elimova, E.1    Kisilevsky, R.2    Szarek, W.A.3    Ancsin, J.B.4
  • 10
    • 18144377807 scopus 로고    scopus 로고
    • In vivo fragmentation of heparan sulfate by heparanase overex-pression renders mice resistant to amyloid protein a amyloidosis
    • doi: 10. 1073/pnas.0502287102
    • Li JP, Galvis ML, Gong F, Zhang X, Zcharia E, Metzger S, Vlodavsky I, Kisilevsky R, Lindahl U (2005) In vivo fragmentation of heparan sulfate by heparanase overex-pression renders mice resistant to amyloid protein A amyloidosis. Proc Natl Acad Sci USA 102: 6473-6477. doi: 10. 1073/pnas.0502287102
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 6473-6477
    • Li, J.P.1    Galvis, M.L.2    Gong, F.3    Zhang, X.4    Zcharia, E.5    Metzger, S.6    Vlodavsky, I.7    Kisilevsky, R.8    Lindahl, U.9
  • 11
    • 0036860278 scopus 로고    scopus 로고
    • Serum amyloid p component scintigraphy for diagnosis and monitoring amyloidosis
    • doi:10. 1097/00041552-200211000-00013
    • Hawkins PN (2002) Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 11:649-655. doi:10. 1097/00041552-200211000-00013
    • (2002) Curr Opin Nephrol Hypertens , vol.11 , pp. 649-655
    • Hawkins, P.N.1
  • 12
    • 77954563049 scopus 로고    scopus 로고
    • A one-center experience with pediatric percutaneous renal biopsy and histopathology in ankara, turkey
    • doi: 10. 1007/s11255-008-9433-9
    • Demircin G, Deliba A, Bek K et al (2008) A one-center experience with pediatric percutaneous renal biopsy and histopathology in Ankara, Turkey. Int Urol Nephrol. doi: 10. 1007/s11255-008-9433-9
    • (2008) Int Urol Nephrol
    • Demircin, G.1    Deliba, A.2    Bek, K.3
  • 13
    • 0033895284 scopus 로고    scopus 로고
    • Presentation, survival and prognostic markers in aa amyloidosis
    • Joss N, McLaughlin K, Simpson K, Boulton-Jones JM (2000) Presentation, survival and prognostic markers in AA amyloidosis. Q J Med 93:535-542
    • (2000) Q J Med , vol.93 , pp. 535-542
    • Joss, N.1    McLaughlin, K.2    Simpson, K.3    Boulton-Jones, J.M.4
  • 14
    • 23244448608 scopus 로고    scopus 로고
    • Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (al): A consensus opinion from the 10th international symposium on amyloid and amyloidosis
    • doi:10. 1002/ ajh. 20381
    • Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Salomon A, Grateau G (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol 79:319-328. doi:10. 1002/ ajh. 20381
    • (2005) Am J Hematol , vol.79 , pp. 319-328
    • Ma, G.1    Comenzo, R.2    Falk, R.H.3    Fermand, J.P.4    Hazenberg, B.P.5    Hawkins, P.N.6    Merlini, G.7    Moreau, P.8    Ronco, P.9    Sanchorawala, V.10    Sezer, O.11    Salomon, A.12    Grateau, G.13
  • 15
    • 11244272941 scopus 로고    scopus 로고
    • The czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000
    • doi:10. 1093/ndt/gfh521
    • Rychlik I, Jancova E, Tesar V et al (2004) The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994-2000. Nephrol Dial Transplant 19:3040-3049. doi:10. 1093/ndt/gfh521
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 3040-3049
    • Rychlik, I.1    Jancova, E.2    Tesar, V.3
  • 16
    • 0029657780 scopus 로고    scopus 로고
    • Shift in the incidence of rheumatoid arthritis towards elderly patients in finland during 1875-1990
    • Kaipiainen-Sepannen O, Aho K, Isomaki H, Laakso M (1996) Shift in the incidence of rheumatoid arthritis towards elderly patients in Finland during 1875-1990. Clin Exp Rheumatol 14:537-542
    • (1996) Clin Exp Rheumatol , vol.14 , pp. 537-542
    • Kaipiainen-Sepannen, O.1    Aho, K.2    Isomaki, H.3    Laakso, M.4
  • 17
    • 0033867112 scopus 로고    scopus 로고
    • Where has secondary amyloidosis gone?
    • doi:10. 1136/ard.59.8.577
    • Hazenberg BPC, van Rijswijk MH (2000) Where has secondary amyloidosis gone? Ann Rheum Dis 59:577-579. doi:10. 1136/ard.59.8.577
    • (2000) Ann Rheum Dis , vol.59 , pp. 577-579
    • Bpc, H.1    Van Rijswijk, M.H.2
  • 19
    • 47349109629 scopus 로고    scopus 로고
    • No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases-data from the finnish national registry for kidney diseases
    • Immonen K, Finne P, Hakala M, Kautiainen H, Pettersson T, Grönhagen-Riska C (2008) No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases-Data from the Finnish national registry for kidney diseases. J Rheumatol 35:7
    • (2008) J Rheumatol , vol.35 , pp. 7
    • Immonen, K.1    Finne, P.2    Hakala, M.3    Kautiainen, H.4    Pettersson, T.5    Grönhagen-Riska, C.6
  • 20
    • 0041310012 scopus 로고    scopus 로고
    • Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients
    • doi:10. 1093/ndt/gfg1043
    • Rysava R, Merta M, Spicka I, Tesar V (2003) Current therapeutic possibilities in primary and secondary amyloidosis and our experience with 31 patients. Nephrol Dial Transplant 18(5):38-40. doi:10. 1093/ndt/gfg1043
    • (2003) Nephrol Dial Transplant 18(5) , pp. 38-40
    • Rysava, R.1    Merta, M.2    Spicka, I.3    Tesar, V.4
  • 21
    • 0035822274 scopus 로고    scopus 로고
    • Amyloid load and clinical outcome in aa amyloidosis in relation to circulating concentration of serum amyloid a protein
    • doi:10. 1016/ S0140-6736(00)05252-1
    • Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358:24-29. doi:10. 1016/ S0140-6736(00)05252-1
    • (2001) Lancet , vol.358 , pp. 24-29
    • Gillmore, J.D.1    Lovat, L.B.2    Persey, M.R.3    Pepys, M.B.4    Hawkins, P.N.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.